Comment by SiliconAlley

I think it could be argued that the entire mechanics of drug development (and costs) would be fundamentally different in an environment without patents. Without the incentive of monopoly, there might be a lot more evolution (think of forking/branching of open source software projects) of meds, which I imagine would significantly alter the costs/incentives in drug development. These are kind of just my thoughts as a layman, though.